Our analysis of possible targets for CCL20 action within the tumour microenvironment implicated microvascular endothelial cells due to their high expression of CCR6 on their cell surface in vitro, and due to the observation of CD31+/CCR6+ vessels closely apposed to tumour tissue of patients. The gene discussed is CCL20; the disease is neoplasm.